Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase I/IIa Dose-escalation Clinical Study of VAC-3S

This study has been completed.
Information provided by (Responsible Party):
InnaVirVax Identifier:
First received: March 2, 2012
Last updated: January 30, 2015
Last verified: January 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2014
  Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)